ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
23andMe Holding Company

23andMe Holding Company (ME)

3.35
0.20
( 6.35% )
更新日時: 02:09:12

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
3.35
買値
3.37
売値
3.39
出来高
154,515
3.10 日の範囲 3.39
2.655 52 週間の範囲 20.40
時価総額
前日終値
3.15
始値
3.15
最終取引時間
02:09:12
財務取引量
US$ 508,215
VWAP
3.2891
平均取引量 (3 か月)
2,134,055
発行済株式数
26,117,997
配当利回り
-
PER
-0.13
1 株当たり利益 (EPS)
-25.53
歳入
219.64M
純利益
-666.7M

23andMe Holding Company について

23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic t... 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. More than 80% of 23andMe customers voluntarily elect to share their de-identified genetic data with the company, which is used to develop future reports. In 2018, GlaxoSmithKline made an equity investment in the company, entering a five-year collaborative agreement with 23andMe to develop drug candidates. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Blank Checks
ウェブサイト
本社
Wilmington, Delaware, USA
設立
2021
23andMe Holding Company is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ME. The last closing price for 23andMe was US$3.15. Over the last year, 23andMe shares have traded in a share price range of US$ 2.655 to US$ 20.40.

23andMe currently has 26,117,997 shares in issue. The market capitalisation of 23andMe is US$82.27 million. 23andMe has a price to earnings ratio (PE ratio) of -0.13.

ME 最新ニュース

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, and Mirador Therapeutics, a...

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, reported its financial results for the second...

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all...

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe Holding Co. (Nasdaq: ME) (23andMe) will report financial results for the...

23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.87-20.61611374414.224.22992.6559661243.22752709CS
4-1.39-29.32489451484.745.3482.6554308883.85561066CS
12-2.85-45.96774193556.27.882.65521340556.1782923CS
26-7.586-69.367227505510.93612.3222.65531625287.72932502CS
52-14.248-80.963745880217.59820.42.655462816611.17432406CS
156-196.65-98.325200202.5622.655358186638.79317474CS
260-128.45-97.4582701062131.8273.62.655283301252.27612051CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 1.90
(93.88%)
114.82M
CRNCCerence Inc
US$ 5.0599
(79.43%)
37.81M
SPAISafe Pro Group Inc
US$ 4.55
(42.19%)
39.54M
QUBTQuantum Computing Inc
US$ 5.03
(36.68%)
100.61M
QMCOQuantum Corporation
US$ 4.08
(35.10%)
555.89k
GLXGGalaxy Payroll Group Ltd
US$ 1.88
(-51.92%)
1.49M
PYXSPyxis Oncology Inc
US$ 2.13
(-44.24%)
10.39M
KURAKura Oncology Inc
US$ 9.98
(-37.27%)
8.31M
WCTWellchange Holdings Company Limited
US$ 2.14
(-35.54%)
646.59k
BLRXBioLineRx Ltd
US$ 0.3521
(-35.42%)
6.54M
CDTConduit Pharmaceuticals Inc
US$ 0.1123
(21.67%)
505.01M
NVDANVIDIA Corporation
US$ 143.33
(-1.75%)
225.41M
AKTSAkoustis Technologies Inc
US$ 0.1028
(18.03%)
187.11M
ELABElevai Labs Inc
US$ 0.0203
(-5.14%)
179.83M
WORXSCWorx Corporation
US$ 1.90
(93.88%)
113.91M

ME Discussion

投稿を表示